OpenBilldrug price receipt

NADAC week of 2026-10-14

HYDROMORPHONE 2 MG TABLET

For 30 tablets

Pharmacies pay

$5.08 filed

30 × $0.16941 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$10.84 estimated

$5.08 + $0.76 (15%) + $5.00 fee per fill = $10.84

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

HYDROMORPHONE 2 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hydromorphone hydrochloride.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them SpecGx LLC, Aurolife Pharma, LLC and Rhodes Pharmaceuticals LLC.

FDA’s Established Pharmacologic Class for it is Opioid Agonist.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes); the FDA directory lists 5 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $5.08 for 30 tablets (30 × $0.16941 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 6 NDCs

Other strengths, forms and brands

12 other products in the NADAC file share the FDA nonproprietary name hydromorphone hydrochloride with HYDROMORPHONE 2 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
HYDROMORPHONE 1 MG/ML SOLUTION
generic · solution
$0.23587 per ML filed
eff. 2026-09-23
We don’t know yet
HYDROMORPHONE 2 MG TABLET this page
generic · tablet
$0.16941 per EA filed
eff. 2026-09-23
We don’t know yet
HYDROMORPHONE 2 MG/ML VIAL
generic · injection / injection, solution
$2.74032 per ML filed
eff. 2026-07-22
$4.48 per ML derived
Part B limit 2026 Q4
HYDROMORPHONE 4 MG TABLET
generic · tablet
$0.21916 per EA filed
eff. 2026-09-23
We don’t know yet
HYDROMORPHONE 5 MG/5 ML SOLN
generic · solution
$0.23587 per ML filed
eff. 2026-09-23
We don’t know yet
HYDROMORPHONE 8 MG TABLET
generic · tablet
$0.56093 per EA filed
eff. 2026-09-23
We don’t know yet
HYDROMORPHONE 10 MG/ML VIAL
generic · injection, solution
$2.56628 per ML filed
eff. 2026-05-20
$22.40 per ML derived
Part B limit 2026 Q4
HYDROMORPHONE 50 MG/5 ML VIAL
generic · injection, solution
$2.56628 per ML filed
eff. 2026-05-20
$22.40 per ML derived
Part B limit 2026 Q4
HYDROMORPHONE 500 MG/50 ML VIAL
generic · injection, solution
$2.56628 per ML filed
eff. 2026-05-20
$22.40 per ML derived
Part B limit 2026 Q4
HYDROMORPHONE 500 MG/50 ML VL
generic · injection, solution
$2.56628 per ML filed
eff. 2026-05-20
$22.40 per ML derived
Part B limit 2026 Q4
HYDROMORPHONE HCL ER 8 MG TAB
generic · tablet, extended release
$5.7288 per EA filed
eff. 2026-09-23
$8.02501 per EA filed
Part D 2024 average
HYDROMORPHONE HCL ER 12 MG TAB
generic · tablet, extended release
$10.42125 per EA filed
eff. 2026-09-23
$8.02501 per EA filed
Part D 2024 average
HYDROMORPHONE HCL ER 16 MG TAB
generic · tablet, extended release
$12.38018 per EA filed
eff. 2026-09-23
$8.02501 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $0.16941 per EA filed.

Of the 108 other products in FDA’s Opioid Agonist class priced per EA, 88 have a higher middle NADAC price and 20 a lower one. The one in the middle is MORPHINE SULF ER 100 MG TABLET, at $0.85389 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.